Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.
Shire Plc Ord 5P is listed on the London Stock Exchange trading with ticker code SHP.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £4,305,985m, with approximately 918m shares in issue. Over the last year, Shire Plc share price has been traded in a range of 1839.5, hitting a high of 4,780.00, and a low of 2,940.50.
Shire Plc, officially known as Shire Plc Ord 5P was formed in March of 1990, making the company twenty nine years old. The company filed its latest accounts on 31st March 2015, showing a turnover of approximately 16.07 million GBX with gross profits of 11.40 million, or 0.0124 per issued share, and a pre-tax profit margin of 11.16%. Shire Plc currently has 10 directors, and has had 3 previous directors over the last 29 years. In the last set of accounts produced by Baker Tilly Uk Audit Llp, the company showed 6.02 million paid in salaries to the 129 staff (average wage of 47 thousand), with the directors receiving an average 112 thousand each. In the accounts filed in 2015, the company paid 1608000 in dividends, or 0.0018 per share. These accounts also showed Shire Plc to have a net worth of 9.82 million, with 1.00 million held in cash.
Shire Plc is in the Medicine and Biotech Research sector.
|Hutchison China Meditech Limited (HCM.L)|
|Btg Plc (BTG.L)|
|Dechra Pharmaceuticals Plc (DPH.L)|
|Rio Tinto Plc (RIO.L)|
|Glaxosmithkline Plc (GSK.L)|
|Shares in Issue||918m|
|52 Week High||4,780.00|
|52 Week Low||2,940.50|